Wal-Mart Stores, Inc., will outfit low- and medium-temperature refrigerated display cases in over 500 U.S. stores with a GE ecomagination-certified, light-emitting diode (LED) solution from GELcore, LLC, a GE Consumer & Industrial business (GE).
More than 20 million Americans suffer from diabetes, a serious, chronic illness. Now, during American Diabetes Month, everyone has an opportunity to make an impact in the fight against the disease, at no cost, with just a click of the mouse. For each visitor who clicks at www.Click4Diabetes.com, a donation will be made to the American Diabetes Association (ADA), the nation’s leading nonprofit health organization providing diabetes research, information and advocacy.
McKesson, the world’s largest healthcare services, automation and information technology company, today announced the general availability of the IntelliShelf-Rx? system for hospital pharmacies. Powered by the same advanced workflow software found in McKesson?s market-leading ROBOT-Rx?, IntelliShelf-Rx is equipped with radio frequency identification (RFID) and bar-coding technologies to that enable hospitals to automate existing medication dispensing processes without reengineering the entire pharmacy. The highly scalable solution is yet another advanced automation offering from McKesson designed to reduce medication dispensing errors, simplify manual tasks, and automate inventory control and management.
Wal-Mart Stores, Inc., (NYSE: WMT) announced that starting today, it is rolling out its $4 generic prescription program in 11 additional states and adding 17 more prescriptions to the program. With the announcement, the expanded $4 generic prescription program will now be available in an additional 502 stores throughout Idaho, Kentucky, Maine, Massachusetts, Nebraska, Oklahoma, Rhode Island, South Carolina, Utah, Washington and West Virginia.
Wal-Mart Stores, Inc., (NYSE: WMT) announced that starting today, it is rolling out its $4 generic prescription program in 11 additional states and adding 17 more prescriptions to the program. With the announcement, the expanded $4 generic prescription program will now be available in an additional 502 stores throughout Idaho, Kentucky, Maine, Massachusetts, Nebraska, Oklahoma, Rhode Island, South Carolina, Utah, Washington and West Virginia.
Listed biopharmaceutical company GroPep Limited (ASX: GRO) todayannounced the release of a novel Assay kit to be used in the detectionof a range of diseases, including cancer.
Virginia Commonwealth University researchers have developed a unique anti-sickling agent that may one day be effective in treating sickle cell disease, a painful and debilitating genetic blood disorder that affects approximately 80,000 Americans.
IT engineers have developed a mathematical model that could help energy companies produce natural gas more efficiently and ensure a more reliable supply of this valuable fuel. The researchers are now collaborating with experts at Shell to apply the model to a natural gas production system in Malaysia.
UCLA researchers report that although the majority of medical journals have conflict of interest policies in place for study authors, less than half require such policies for editors or peer-reviewers. In addition, many journals do not inform readers about those potential conflicts that have been disclosed to them.
A new lab-on-a-chip can identify single bacterial cells for the most common cases of drug-resistant pneumonia, cutting down the wait from days to hours for identifying the particular strain and treating it.